Table 3-24 Eosinophilic and Neutrophilic Dermatoses |
| Entity | | Clinical Findings | | Histology/Treatment |
Eosinophilic Dermatoses |
| Eosinophilic pustular folliculitis (Ofuji’s disease) (Figure 3.44C) | | Erythematous follicular papules, pustules, and plaques with annular or serpiginous pattern, occurring in recurrent crops; typically on face in men, associated pruritus | | Histology: ↑↑ eosinophils around follicles, exocytosis of eosinophils and lymphocytes into follicular epithelium |
| | | Treatment: indomethacin (first line), dapsone, phototherapy, oral corticosteroid or minocycline (topical steroid if mild) |
| Eosinophilic folliculitis (AIDS-associated) (Figure 3.44B) | | Follicular papules erupting over face, ± scalp and upper trunk; associated with significant pruritus and ↓↓ CD4 count | | Histology: similar to Ofuji’s disease |
| | | Treatment: antiretroviral therapy to ↑ CD4 count, phototherapy, topical corticosteroid with oral antihistamine |
| Angiolymphoid hyperplasia with eosinophilia (Figure 3.44A) | | Red to pink to brown papules or nodules typically over scalp, around ears or forehead, ± grouped, ± painful | | Histology: vascular proliferation with ‘hobnail’ endothelial cells (protrude into lumen), surrounding eosinophils |
| | | Treatment: surgical excision (1/3 recur) |
Neutrophilic Dermatoses |
| Behçet’s disease (Figure 3.44D–F) | | Ulcerations; acneiform, papulopustular, EN-like or pseudofolliculitis-type lesions; ± arthritis, neurologic involvement, bowel aphthae, thrombophlebitis; HLA-B51 | | Histology: ulcerated epidermis or superficial pustule, diffuse neutrophilic infiltrate in dermis, ± lymphocytes, histiocytes, sometimes vasculitis |
| | | Treatment: colchicine, dapsone, thalidomide, TNF-inhibitors
{Diagnostic criteria: oral ulcers (at least three times in 12 month period) PLUS at least two of the following: - recurrent genital ulcers - positive pathergy test - ocular (uveitis, retinal vasculitis) - skin findings (see above)} |
| Sweet’s syndrome (Figure 3.45A) | | Tender, erythematous edematous papules and plaques typically over face or upper extremities; ± fever, malaise, leukocytosis; vesicobullous variant frequently associated with myelogenous leukemia | | Histology: variable epidermal changes, superficial dermal edema with diffuse neutrophilic infiltrate ± lymphocytes, histiocytes, eosinophils, no true vasculitis |
| | | Treatment: oral corticosteroid × 4–6 weeks, KI, dapsone, colchicine; 30% recurrence { Diagnostic criteria: abrupt-onset of typical eruption + typical histopathological findings PLUS 2 of following: - preceded by associated infection/vaccination, drug exposure, current malignancy/inflammatory disorder or pregnancy
- fever and constitutional symptoms 3. leukocytosis 4. excellent response to systemic corticosteroids}
|
| Pyoderma gangrenosum (Figure 3.45B, C)
{Vesicobullous type most common with acute or chronic myelogenous leukemia} | | Tender papulopustule with violaceous induration → bulla or expanding ulcer w/ purulent base, undermined border; cribriform scar; pustular, bullous, granulomatous variants
{50% PG with systemic disease: IBD, arthritis or hematological disorders (if monoclonal gammopathy, usually IgA)} | | Histology: early lesions with leukocytoclasia, neutrophilic infiltrate, advanced lesions with marked necrosis of tissue with infiltrate of mononuclear cells |
| | | Treatment: none with consistent efficacy; oral corticosteroid ± steroid-sparing agents |
| | | | | |